Essex Woodlands IX, LLC, 10% Owner at EyePoint Pharmaceuticals, Inc. (EYPT), sold 278,615 shares at $11.02 ($2.9M) on 2023-08-31, disclosed to the SEC on 2023-09-01.
Open-market sale of $2.9M EYPT by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.92 | 60,649 | $662K | 22.6% |
| 2 | $10.92 | 60,649 | $662K | 22.6% |
| 3 | $11.36 | 327 | $4K | 0.1% |
| 4 | $10.17 | 71,478 | $727K | 24.8% |
| 5 | $10.17 | 71,478 | $727K | 24.8% |
| 6 | $11.02 | 7,017 |
| $77K |
| 2.6% |
| 7 | $11.02 | 7,017 | $77K | 2.6% |
| Total | $10.54 avg | 278,615 | $2.9M | 100% |
| Filing → |
| EYPT | BUY | 2018-07-03 | $42.8M | — | Filing → |